info@tiba.bio
 

Media CoverageNext-Gen RNA Vaccine Technology Focuses on Disease X

January 19, 2023

Precision Vaccinations reports on CEPI and Tiba Biotech’s partnership to evaluate next-generation RNA vaccine platform technology.  Read more

previous
Major Boost for mRNA Vaccines Targeting ‘Disease X’
next
CEPI Assessing Advanced RNA Nanoparticle Vaccine
https://i0.wp.com/tiba.bio/wp-content/uploads/2021/05/Tiba-small-logo2.png?fit=140%2C58&ssl=1
info@tiba.bio
1 Broadway, 14th Fl., Cambridge MA

Keep connected with us

Check out our careers page
See what we are doing!

© 2024 Tiba Biotech LLC. All rights reserved

Terms and Conditions